The $25M Cancer Research Fight That Just Reached Parliament

Jan de Vries · 2026-09-08

When a disease gets far less attention than it deserves, the numbers tell a heartbreaking story. Invasive lobular breast cancer is the second most common type of breast cancer, yet it receives a fraction of the research funding that other forms get. That gap finally got noticed at the highest level of government, and the push for change just got real. Campaigners have spent years trying to close this funding gap, and their latest move targeted Andy Burnham during Prime Minister's Questions. The ask? A dedicated $25 million research fund for invasive lobular breast cancer. That's roughly £20 million, but for U.S. readers, let's be clear: we're talking about a serious chunk of change that could reshape how this disease is understood and treated. ### Why Invasive Lobular Breast Cancer Gets Overlooked Here's the thing about invasive lobular breast cancer: it doesn't always show up on mammograms the way other breast cancers do. It grows in a more diffuse pattern, which makes it harder to detect early. That means women often get diagnosed at later stages, and the treatment options become more limited. Despite being the second most common type of breast cancer, it gets a tiny slice of the research pie. Most studies focus on the more common invasive ductal carcinoma, leaving lobular patients with fewer targeted therapies and less understanding of how the disease progresses. The campaigners aren't asking for a handout. They're asking for fairness. And they're asking for it in the most public way possible. ### The PMQs Moment Prime Minister's Questions is where political pressure gets applied in full view of the nation. It's the weekly spectacle where opposition leaders and backbenchers grill the Prime Minister on the issues that matter most to their constituents. By bringing this fight to PMQs, the campaigners ensured that the funding gap for invasive lobular breast cancer became a national talking point. It wasn't just a niche health issue anymore. It was a question of political will, and the pressure was squarely on Andy Burnham to respond. Burnham, who has been a vocal advocate for health causes throughout his career, found himself in the spotlight. The campaigners made it clear that they expect more than sympathy. They want a commitment, and they want it in writing. ### What $25 Million Could Actually Do Let's put that number in perspective. Twenty-five million dollars won't cure cancer overnight, but it could fund: - Dedicated clinical trials specifically for invasive lobular breast cancer patients - Research into better imaging techniques to catch the disease earlier - Studies on why lobular cancer responds differently to existing treatments - Support for the small but growing community of researchers focused on this subtype For a disease that affects roughly one in ten breast cancer patients, that kind of targeted investment could be transformative. It could mean earlier diagnoses, better treatment protocols, and ultimately, more women surviving. ### The Bigger Picture This isn't just about one politician or one funding request. It's about how we decide which diseases get attention and which ones get ignored. It's about the uncomfortable truth that research funding often follows advocacy power, not patient need. The campaigners have shown what determination looks like. They've taken a complex scientific issue and turned it into a political imperative. They've made it impossible for policymakers to claim they didn't know about the problem. And that's exactly the point. When you bring a health crisis to the floor of Parliament, you're saying that this matters as much as any other national priority. You're saying that the women affected by this disease deserve the same shot at survival as anyone else. ### What Happens Next Andy Burnham hasn't made a firm commitment yet, but the pressure isn't going away. The campaigners have made it clear that they'll keep pushing until they get a definitive answer. For anyone following this story, the takeaway is simple: advocacy works. It's slow, it's frustrating, and it often feels like shouting into the void. But sometimes, it gets you to the floor of Parliament with the whole country watching. Whether the $25 million materializes remains to be seen. But the conversation has started, and that's a victory in itself. The women living with invasive lobular breast cancer just got a little more visible, and that visibility could be the first step toward the research they desperately need.